Surgalign Holdings, Inc. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was USD 81.98 million compared to USD 90.5 million a year ago. Net loss was USD 54.61 million compared to USD 84.65 million a year ago.

Basic loss per share from continuing operations was USD 8.33. Diluted loss per share from continuing operations was USD 8.33. Basic loss per share was USD 8.33 compared to USD 20.72 a year ago.

Diluted loss per share was USD 8.33 compared to USD 20.72 a year ago.